Form 4: Director Katz Receives Restricted Stock Units in NeuroMetrix, Inc.

Director Nancy E. Katz was granted 13,730 restricted stock units in NeuroMetrix, Inc. on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Summary

• On May 22, 2024, Nancy E. Katz, a director of NeuroMetrix, Inc., received 13,730 restricted stock units (RSUs).
• The RSUs will vest 100% on the earlier of the date of the 2025 annual meeting of stockholders or a change in control of NeuroMetrix, Inc., contingent upon Katz's continued service on the Board of Directors.
• The exercise price of the derivative security is $4.37.
• The price was determined based on the Nasdaq market on April 30, 2024.

Sentiment

Score: 6

Explanation: The document reflects a routine grant of stock units, which is neutral to slightly positive as it incentivizes the director. There are no indications of significant positive or negative sentiment.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• Vesting is tied to continued service and company events, incentivizing long-term commitment.

Future Outlook

The vesting of the RSUs is contingent upon continued service and a future event (annual meeting or change in control), indicating an expectation of ongoing involvement.

Industry Context

Grants of restricted stock units are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Restricted stock units are a standard component of compensation packages for directors in publicly traded companies like NeuroMetrix.
• Companies such as Medtronic and Boston Scientific also use RSUs to incentivize and retain board members.
• The vesting schedules and terms are generally comparable to industry norms, often tied to continued service and company performance.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value through equity ownership.
• Employees: May have a minor indirect impact on employee morale as it reflects executive compensation practices.

Next Steps

• Continued service by Nancy E. Katz on the Board of Directors.
• Holding of the 2025 annual meeting of stockholders.
• Potential change in control of NeuroMetrix, Inc.

Key Dates

Keywords

NeuroMetrix, Restricted Stock Units, Director, Form 4, Beneficial Ownership, Katz, NURO